Giulio Francesco Romiti

Pubblicazioni

Titolo Pubblicato in Anno
Educational status and the risk of adverse outcomes in Asian patients with atrial fibrillation: a report from the prospective APHRS-AF Registry MINERVA MEDICA 2024
A Focus on the Pathophysiology of Adrenomedullin Expression: Endothelitis and Organ Damage in Severe Viral and Bacterial Infections CELLS 2024
Combination therapy of beta-blockers and digoxin is associated with increased risk of major adverse cardiovascular events and all-cause mortality in patients with atrial fibrillation: a report from the GLORIA-AF registry INTERNAL AND EMERGENCY MEDICINE 2024
Impact of Frailty Dynamics in Patients With Atrial Fibrillation: Learning How Clinical Complexity Increases Risk in Cardiovascular Diseases CIRCULATION. CARDIOVASCULAR QUALITY AND OUTCOMES 2024
Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry EUROPEAN JOURNAL OF INTERNAL MEDICINE 2024
Anticoagulation in patients with atrial fibrillation and chronic kidney disease: clinical complexity beyond thromboembolism INTERNAL AND EMERGENCY MEDICINE 2024
Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: A report from the GLORIA-AF registry phase III DIABETES, OBESITY AND METABOLISM 2024
The 2024 ESC Guidelines for diagnosis and management of AF: A clinicians’ perspective THROMBOSIS AND HAEMOSTASIS 2024
Efficacy of the ABC Pathway for Integrated Care Across Phenotypes of Patients with Atrial Fibrillation: A Latent-Class Analysis Report from the mAFA-II Clinical Trial JOURNAL OF GENERAL INTERNAL MEDICINE 2024
In subclinical AF, the benefit of apixaban vs. aspirin on stroke or systemic embolism trended higher with CHA2DS2-VASc >4 ANNALS OF INTERNAL MEDICINE 2024
Adverse events in clinically complex elderly patients with atrial fibrillation according to oral anticoagulation status ECLINICALMEDICINE 2024
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation: analysis from two prospective observational registries BMC MEDICINE 2024
Inflammation, lipids and cardiovascular risk: The quest for improving risk stratification and prognosis in ischemic heart disease EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 2024
Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC‐EHRA EORP Atrial Fibrillation Long‐Term General Registry JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE 2024
Efficacy of mobile health-technology integrated care based on the 'Atrial fibrillation Better Care' (ABC) pathway in relation to sex: a report from the mAFA-II randomized clinical trial INTERNAL AND EMERGENCY MEDICINE 2023
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients JOURNAL OF CLINICAL MEDICINE 2023
Single-lead VDD pacing: a literature review on short-term and long-term performance EXPERT REVIEW OF MEDICAL DEVICES 2023
Mobile health-technology integrated care in secondary prevention atrial fibrillation patients: a post-hoc analysis from the mAFA-II randomized clinical trial INTERNAL AND EMERGENCY MEDICINE 2023
Distinct platelet crosstalk with adaptive and innate immune cells after adenoviral and mRNA vaccination against SARS-CoV-2 JOURNAL OF THROMBOSIS AND HAEMOSTASIS 2023
Yield of Diagnosis and Risk of Stroke with Screening Strategies for Atrial Fibrillation: A Comprehensive Review of Current Evidence EUROPEAN HEART JOURNAL OPEN 2023

ERC

  • LS4_10
  • LS7_12
  • LS7_14

KET

  • Big data & computing

Interessi di ricerca

Atrial Fibrillation

Clinical Complexity

Integrated Care

Frailty

Multimorbidity

Keywords

atrial fibrillation
anticoagulants
complexity
multimorbidity
frailty

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma